HIV uses autophagy for its own means

July 27, 2009
Kyei et al. found that the HIV Gag protein (green) localized to autophagosomes (red). Another HIV protein, Nef, blocks the later stages of autophagosome maturation to allow full Gag processing and increase viral yield. Credit: Kyei, G.B., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200903070

Not satisfied with simply thwarting its host's defensive maneuvers, HIV actually twists one to its advantage, based on new findings from Kyei et al. in the July 27, 2009 issue of the Journal of Cell Biology. Vojo Deretic and colleagues suggest that autophagy—a stress response process—helps HIV to proliferate and that conversely, blocking autophagy lessens HIV production.

Reduced levels were accompanied by a blockade in the processing of Gag—a key precursor protein for HIV assembly. Gag in fact localized to complexes containing an autophagy protein, LC3. "It looked paradoxical," says Deretic. "But only if you didn't know something else. And that is a finding in yeast that autophagy is not only degradative, but can also serve in some biosynthetic pathways," including the trafficking of the Cvt protein to the vacuole. Together, the results suggest that Gag may piggyback on autophagosomes or their components, perhaps for locomotive services, to complete its maturation.

The group then sought the viral agitator that blocks autophagosome maturation and allows Gag processing. Their primary candidate was HIV protein Nef, which interacts with the vacuolar proton ATPase and might thereby block acidification steps necessary to make a degradative organelle. Using a mutant virus, the group showed that HIV lacking Nef no longer profited from increased autophagy and was instead degraded. It is not yet clear exactly how Nef blocks autophagosome maturation.

Clinical applications may be far down the road. If the idea is to kill the virus using drugs such as , which induces autophagy, it will first be necessary to block Nef, notes Deretic. The idea is not without natural support. "There were cases in Australia involving HIV strains that lacked Nef," he says. "And these people would not progress to AIDS, meaning the virus is disabled."

Deretic has other exciting ideas. Highly active anti-retroviral therapy often does a smashing job clearing viral loads from the blood. But the pathogen can persist in particular locales such as gut lymphoid tissue. "My hope," says Deretic, "is to go after these reservoirs and chew up the virus that for some reason is not readily accessible or susceptible to the anti-retroviral therapy. I have great hope that autophagy will help us with that. This is something we didn't have on our radar screens just five years ago."

More information: Kyei, G.B., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200903070 .

Source: Rockefeller University (news : web)

Related Stories

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.